The Use of 18F-FET-PET-MRI in Neuro-Oncology: The Best of Both Worlds—A Narrative Review
Authors:
- Tineke van de WeijerTWTineke van de Weijer
- Martijn P. G. BroenMBMartijn P. G. Broen
- Rik P. M. MoonenRMRik P. M. Moonen
- Ann HoebenAHAnn Hoeben
- Monique AntenMAMonique Anten
- Koos HovingaKHKoos Hovinga
- Inge CompterICInge Compter
- Jochem A. J. van der PolJPJochem A. J. van der Pol
- Cristina MiteaCMCristina Mitea
- Toine M. LodewickTLToine M. Lodewick
- Arnaud JacquerieAJArnaud Jacquerie
- Felix M. MottaghyFMFelix M. Mottaghy
Open Access
- 11 May 2022
- journal article
- review article
- Published by MDPI AG in Diagnostics
- Vol. 12 (5) , 1202
Abstract
Gliomas are the most frequent primary tumors of the brain. They can be divided into grade II-IV astrocytomas and grade II-III oligodendrogliomas, based on their histomolecular profile. The prognosis and treatment is highly dependent on grade and well-identified prognostic and/or predictive molecular markers. Multi-parametric MRI, including diffusion weighted imaging, perfusion, and MR spectroscopy, showed increasing value in the non-invasive characterization of specific molecular subsets of gliomas. Radiolabeled amino-acid analogues, such as 18F-FET, have also been proven valuable in glioma imaging. These tracers not only contribute in the diagnostic process by detecting areas of dedifferentiation in diffuse gliomas, but this technique is also valuable in the follow-up of gliomas, as it can differentiate pseudo-progression from real tumor progression. Since multi-parametric MRI and 18F-FET PET are complementary imaging techniques, there may be a synergistic role for PET-MRI imaging in the neuro-oncological imaging of primary brain tumors. This could be of value for both primary staging, as well as during treatment and follow-up.Keywords
This publication has 69 references indexed in Scilit:
- 2-hydroxyglutarate detection by magnetic resonance spectroscopy in IDH-mutated patients with gliomasNature Medicine, 2012
- The Added Value of Apparent Diffusion Coefficient to Cerebral Blood Volume in the Preoperative Grading of Diffuse GliomasAmerican Journal of Neuroradiology, 2011
- O-(2-18F-Fluoroethyl)-L-Tyrosine PET Predicts Failure of Antiangiogenic Treatment in Patients with Recurrent High-Grade GliomaJournal of Nuclear Medicine, 2011
- Assessment of perfusion MRI-derived parameters in evaluating and predicting response to antiangiogenic therapy in patients with newly diagnosed glioblastomaNeuro-Oncology, 2010
- Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working GroupJournal of Clinical Oncology, 2010
- Preoperative Grading of Presumptive Low-Grade Astrocytomas on MR Imaging: Diagnostic Value of Minimum Apparent Diffusion CoefficientAmerican Journal of Neuroradiology, 2008
- Advances in Evaluation of Primary Brain TumorsSeminars in Nuclear Medicine, 2008
- Prognostic Value of 18F-Fluoroethyl-l-Tyrosine PET and MRI in Small Nonspecific Incidental Brain LesionsJournal of Nuclear Medicine, 2008
- Diffusional kurtosis imaging: The quantification of non‐gaussian water diffusion by means of magnetic resonance imagingMagnetic Resonance in Medicine, 2005
- O-(2-[18F]fluoroethyl)-L-tyrosine PET combined with MRI improves the diagnostic assessment of cerebral gliomasBrain, 2005